Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

6,087 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Joint diseases and matrix metalloproteinases: a role for MMP-13.
Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. Takaishi H, et al. Among authors: okada y. Curr Pharm Biotechnol. 2008 Feb;9(1):47-54. doi: 10.2174/138920108783497659. Curr Pharm Biotechnol. 2008. PMID: 18289056 Review.
Matrix-degrading metalloproteinases and their roles in joint destruction.
Okada Y. Okada Y. Mod Rheumatol. 2000 Sep;10(3):121-8. doi: 10.3109/s101650070018. Mod Rheumatol. 2000. PMID: 24383588
[Degradation of extracellular matrix by matrix metalloproteinases and joint destruction].
Okada Y, Hashimoto G. Okada Y, et al. Seikagaku. 2001 Nov;73(11):1309-21. Seikagaku. 2001. PMID: 11831026 Review. Japanese. No abstract available.
Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.
Nakamura H, Fujii Y, Inoki I, Sugimoto K, Tanzawa K, Matsuki H, Miura R, Yamaguchi Y, Okada Y. Nakamura H, et al. Among authors: okada y. J Biol Chem. 2000 Dec 8;275(49):38885-90. doi: 10.1074/jbc.M003875200. J Biol Chem. 2000. PMID: 10986281
Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Nakamura H, et al. Among authors: okada y. Eur J Biochem. 1998 Apr 1;253(1):67-75. doi: 10.1046/j.1432-1327.1998.2530067.x. Eur J Biochem. 1998. PMID: 9578462
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).
Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Hashimoto G, et al. Among authors: okada y. FEBS Lett. 2001 Apr 13;494(3):192-5. doi: 10.1016/s0014-5793(01)02323-7. FEBS Lett. 2001. PMID: 11311239
Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y. Okada Y. Verh Dtsch Ges Pathol. 2000;84:33-42. Verh Dtsch Ges Pathol. 2000. PMID: 11217446
Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S. Sameshima T, et al. Among authors: okada y. Cancer Lett. 2000 Sep 1;157(2):177-84. doi: 10.1016/s0304-3835(00)00485-7. Cancer Lett. 2000. PMID: 10936678
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Yoshihara Y, et al. Among authors: okada y. Ann Rheum Dis. 2000 Jun;59(6):455-61. doi: 10.1136/ard.59.6.455. Ann Rheum Dis. 2000. PMID: 10834863 Free PMC article.
Expression of matrix metalloproteinases in gastric carcinoma and possibility of clinical application of matrix metalloproteinase inhibitor in vivo.
Otani Y, Kubota T, Sakurai Y, Igarashi N, Yokoyama T, Kimata M, Wada N, Kameyama K, Kumai K, Okada Y, Kitajima M. Otani Y, et al. Among authors: okada y. Ann N Y Acad Sci. 1999 Jun 30;878:541-3. doi: 10.1111/j.1749-6632.1999.tb07721.x. Ann N Y Acad Sci. 1999. PMID: 10415767 No abstract available.
6,087 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback